Protara Therapeutics, Inc.
TARA
$5.42
$0.163.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.65% | 62.79% | 36.43% | 125.20% | 159.67% |
| Total Receivables | -- | -- | -- | 1,500.00% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -24.35% | -48.72% | -40.47% | -20.80% | 4.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 112.94% | -43.59% | -14.01% | -40.99% | -53.11% |
| Total Current Assets | -7.35% | 59.43% | 35.65% | 118.49% | 150.57% |
|
|
|||||
| Total Current Assets | -7.35% | 59.43% | 35.65% | 118.49% | 150.57% |
| Net Property, Plant & Equipment | -25.54% | -23.88% | -22.11% | -20.08% | -19.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.02% | 10.93% | 9.57% | -2.43% | 8.89% |
| Total Assets | 15.44% | 53.72% | 54.39% | 147.39% | 129.82% |
|
|
|||||
| Total Accounts Payable | -21.70% | 96.25% | 282.60% | 137.65% | 81.96% |
| Total Accrued Expenses | 15.18% | -20.56% | 1.08% | 0.26% | 97.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.50% | 13.07% | 15.85% | 17.00% | 14.34% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -0.20% | 14.66% | 72.82% | 27.58% | 78.26% |
|
|
|||||
| Total Current Liabilities | -0.20% | 14.66% | 72.82% | 27.58% | 78.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -36.98% | -33.39% | -30.39% | -27.68% | -25.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -8.83% | 0.37% | 30.35% | 3.57% | 34.68% |
|
|
|||||
| Common Stock & APIC | 21.02% | 32.90% | 32.95% | 53.88% | 53.35% |
| Retained Earnings | -23.45% | -22.78% | -23.02% | -21.47% | -22.26% |
| Treasury Stock & Other | 4,400.00% | 393.10% | -- | 9,000.00% | 106.45% |
| Total Common Equity | 17.52% | 61.74% | 56.90% | 171.35% | 144.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.52% | 61.74% | 56.90% | 171.35% | 144.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.52% | 61.74% | 56.90% | 171.35% | 144.63% |
|
|
|||||